Skip to content

Neuronetics STIM Gross Profit

Gross Profit at other companies

Stereotaxis logo
StereotaxisSTXS
$3.79M-6.6%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$18.05M+4.1%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$7.76M+51.1%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$139.55M+14.7%
Myriad Genetics logo
Myriad GeneticsMYGN
$137.6M+2.5%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Segments

By segment

See full
Medical Device$10.07M-1.0%
Clinical Services$6.09M+9.2%

Other financials

Income statement

See full
Revenue$34.5M+7.8%
Operating income-$9.0M+18.3%
Net income-$10.8M+14.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$13.2M-34.7%
Total debt$85.4M+3.5%
Total equity$13.3M-62.6%
Total assets$125.4M-11.7%

Cash flow

See full
Operating cash flow-$9.4M+44.6%
CapEx$197.0K-10.0%
Free cash flow-$9.6M+44.1%

Valuation

See full
Market cap$90.46M-59.6%
Enterprise value$162.64M-44.6%
P/S0.6×-1.4×

Profitability

See full
Gross margin48%-15.6pp
Operating margin-19.4%-6.9pp
Net margin-24.5%-8.7pp
FCF margin-9.4%-4.1pp

Returns & leverage

See full
Return on equity-152.4%-1.4pp
Debt / equity6.4×+4.1×
Current ratio1.7×-0.8×

Where this comes from

Calculated from Neuronetics’s reported figures.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuronetics's gross profit?
Neuronetics (STIM) reported gross profit of $16.15M in Q1 2026.
How has Neuronetics's gross profit changed year-over-year?
Neuronetics's gross profit increased by 2.6% year-over-year, from $15.74M to $16.15M.
What is the long-term trend for Neuronetics's gross profit?
Over 4 years (2021 to 2025), Neuronetics's gross profit has grown at a 13.4% compound annual growth rate (CAGR), from $43.66M to $72.31M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.